MEDNAX, Inc. (MD) plummeted -8.08 percent and ended the day at $61.3. The Average Volume of the company is 668.88 Million and P/E (price to earnings) ratio is 17.55, while Forward P/E ratio is 13.24.
Robert W. Baird Downgrade its coverage for MEDNAX, Inc. (MD) in a note sent to investors on 21-Mar-17. The research firm Downgrade the stock to Neutral. Moreover, JP Morgan issued Downgrade rating for the stock on 10-Mar-17. Jefferies also Downgrade the company to Hold on 13-Dec-16, 2016. Additionally, Goldman Initiated its ratings on the stock to Neutral.
The highest price MD stock touched in the last 12 month was $76.96 and the lowest price it hit in the same period was $59.36. The stock has a Return on Assets of 6.5 percent, Return on Investment of 8.6 percent and a Return on Equity of 12.4 percent. The company’s market cap is $5.64 Billion.
MEDNAX, Inc. (MD)’s growth estimate is 1.1 percent for the current quarter. The growth estimate for the next quarter is 3.9 percent. The company’s stock has climbed 14.88 percent in the past five year. The company is expected to grow by 14.6 percent over the next five years.
MEDNAX, Inc. (MD) has been given an average price target of $68.3 from analysts, according to data collected by Finviz.
Now we look at the Moving Averages, the 200-day is -9.36, the 50-day is -11.49 and the 20-day is -10.42. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.
Looking forward, the company is expected to report earnings of $1.07 per share for the current quarter. Revenue is expected in between 859 Million and 822.3 Million with an average of 839.65 Million.
MEDNAX, Inc. (MD) has a mean recommendation of 2.64, according to data compiled by Zacks Investment Research. The recommendation scale measures the value from 1 to 5, where 1 means ‘’Strong Buy’’ and 5 stands for ’’Sell’’.
MEDNAX, Inc. (MD) performance during the last one year Degraded -12.78 percent, while its year to date (YTD) performance showed a Negative trend of -8.04 percent. The stock Fell -8.48 percent over the past six months. The stock’s quarterly performance indicates a Negative momentum of -12.27 percent, whereas its last one month trend is Pessimistic with -10.22 percent. Its weekly performance showed a downward trend of -9.77 percent.
Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 10.2 percent, operating profit margin was 18 percent, whereas gross profit margin stands at 0 percent. Beta factor was calculated at 0.68.
MEDNAX, Inc. (MD) has 92.89 Million shares outstanding and 90.9 Million shares were floated in market. The short ratio in the company’s stock is documented at 14.63 and the short float is around of 10.77%. The stock’s average true range of stands at 1.37, while the relative strength index is 16.36.
Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 1.3, current ratio was 1.3, LT Debt/Equity ratio was 0.61 and Total Debt/Equity ratio was 0.62.